6589 台康生技歷年利潤比率
| 年度/季別 | 毛利率 | 營業利益率 | 稅前淨利率 | 稅後淨利率 |
|---|
| 2025Q2 | 7.98% | -58.70% | -160.58% | -160.77% |
| 2025Q1 | 9.43% | -122.48% | -86.16% | -86.35% |
| 2024Q4 | 33.97% | -71.57% | -39.73% | -39.91% |
| 2024Q3 | 31.74% | -99.05% | -103.01% | -103.18% |
| 2024Q2 | 9.02% | -114.86% | -89.36% | -89.54% |
| 2024Q1 | 8.14% | -97.42% | -47.15% | -47.35% |
| 2023Q4 | 35.14% | -78.02% | -88.82% | -88.91% |
| 2023Q3 | 26.26% | -94.29% | -52.64% | -52.84% |
| 2023Q2 | -13.02% | -185.03% | -140.00% | -140.30% |
| 2023Q1 | 17.93% | -101.91% | -93.93% | -94.07% |
| 2022Q4 | 50.20% | -16.24% | -25.67% | -25.69% |
| 2022Q3 | 42.28% | -39.20% | -7.51% | -7.62% |
| 2022Q2 | 43.51% | -25.39% | 2.02% | 1.91% |
| 2022Q1 | 67.94% | -9.73% | 3.92% | 3.83% |
| 2021Q4 | 52.16% | 2.33% | 0.80% | 0.73% |
| 2021Q3 | 81.42% | 48.76% | 50.61% | 50.57% |
| 2021Q2 | 50.69% | -43.39% | -39.51% | -39.66% |
| 2021Q1 | 60.77% | -92.62% | -93.85% | -93.98% |
| 2020Q4 | 61.21% | -115.98% | -124.53% | -124.67% |
| 2020Q3 | 79.54% | -15.22% | -17.80% | -17.80% |
| 2020Q2 | 62.05% | -147.47% | -155.66% | -155.66% |